Compare OGN & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | CRSR |
|---|---|---|
| Founded | 1923 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2020 |
| Metric | OGN | CRSR |
|---|---|---|
| Price | $13.49 | $8.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $11.40 | $8.50 |
| AVG Volume (30 Days) | 2.4M | ★ 4.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ 87.37 |
| EPS | ★ 0.55 | 0.11 |
| Revenue | ★ $6,216,000,000.00 | $1,472,480,000.00 |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | $6.90 |
| P/E Ratio | ★ $24.49 | $80.00 |
| Revenue Growth | N/A | ★ 11.86 |
| 52 Week Low | $5.69 | $4.48 |
| 52 Week High | $13.49 | $13.10 |
| Indicator | OGN | CRSR |
|---|---|---|
| Relative Strength Index (RSI) | 71.58 | 46.88 |
| Support Level | $10.05 | $8.18 |
| Resistance Level | N/A | $8.44 |
| Average True Range (ATR) | 0.05 | 0.53 |
| MACD | -0.08 | -0.15 |
| Stochastic Oscillator | 95.83 | 22.10 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).